SeeSee

CellSee (formerly CellSee Diagnostics) is a biotechnology and life sciences company that develops advanced platforms for the isolation, detection, and analysis of circulating tumor cells (CTCs) and other rare cells from blood. Headquartered in Ann Arbor, Michigan, the company's proprietary microfluidic technology allows for high-throughput, label-free cell enrichment based on physical properties such as size and deformability. This approach enables comprehensive downstream single-cell analysis, including genomic and proteomic profiling, to support cancer research and drug development. CellSee’s platform is utilized in liquid biopsy applications to provide high-resolution insights into tumor heterogeneity, treatment response, and minimal residual disease, facilitating the advancement of precision medicine.